Hiroyuki Sakurai Selected Research

Adenocarcinoma

5/2022	Concomitant splenic artery ligation has no preventive effect on left-sided portal hypertension following pancreaticoduodenectomy with the resection of the portal and superior mesenteric vein confluence for pancreatic ductal adenocarcinoma.
1/2022	Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy.
1/2022	Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma: CEA Level Before Operation is a Significant Prognostic Indicator in Patients With Locally Advanced Pancreatic Cancer Treated With Neoadjuvant Therapy Followed by Surgical Resection: A Retrospective Analysis.
12/2021	Clinical significance and predictors of complete or near-complete histological response to preoperative chemoradiotherapy in patients with localized pancreatic ductal adenocarcinoma.
7/2021	HER2-positive adenocarcinoma arising from heterotopic pancreas tissue in the duodenum: A case report.
1/2021	Phase I Study of Preoperative Chemoradiotherapy Using Gemcitabine Plus Nab-Paclitaxel for Patients Who Have Localized Pancreatic Ductal Adenocarcinoma With Contact or Invasion to Major Arteries.
4/2019	Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.
3/2019	The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.
1/2019	Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes.
1/2019	Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Sakurai Research Topics

Disease

50	Neoplasms (Cancer) 12/2022 - 07/2004
22	Adenocarcinoma 05/2022 - 01/2012
15	Wounds and Injuries (Trauma) 01/2022 - 02/2002
13	Burns 05/2014 - 02/2002
9	Infections 01/2021 - 01/2007
8	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2006
8	Acute Lung Injury 12/2012 - 09/2005
7	Reperfusion Injury 01/2021 - 02/2009
7	Head and Neck Neoplasms (Head and Neck Cancer) 11/2019 - 04/2009
6	Venous Thrombosis (Deep-Vein Thrombosis) 05/2020 - 11/2005
6	Port-Wine Stain (Nevus Flammeus) 03/2009 - 02/2006
5	Pancreatic Fistula (Pancreatic Fistulas) 06/2022 - 08/2010
5	Thrombosis (Thrombus) 07/2020 - 03/2007
5	Lymphatic Metastasis 05/2020 - 03/2005
5	Liver Diseases (Liver Disease) 01/2020 - 04/2009
4	Hypersensitivity (Allergy) 01/2022 - 01/2007
4	Neoplasm Metastasis (Metastasis) 12/2021 - 04/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 05/2015
4	Squamous Cell Carcinoma of Head and Neck 11/2019 - 04/2009
4	Necrosis 07/2018 - 02/2009
4	Liver Cirrhosis (Hepatic Cirrhosis) 03/2018 - 07/2008
4	Lung Neoplasms (Lung Cancer) 02/2018 - 05/2005
4	Thrombocytopenia (Thrombopenia) 01/2016 - 07/2008
4	Non-alcoholic Fatty Liver Disease 08/2014 - 05/2010
4	Smoke Inhalation Injury 11/2012 - 11/2010
4	Cicatrix (Scar) 09/2012 - 01/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2012
3	Carcinoma (Carcinomatosis) 01/2022 - 07/2004
3	Allergic Rhinitis 01/2022 - 11/2018
3	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2014
3	Inflammation (Inflammations) 01/2021 - 01/2017
3	Cholangiocarcinoma 01/2021 - 10/2009
3	Hemorrhage 10/2020 - 07/2008
3	Klatskin Tumor 05/2020 - 01/2017
3	Margins of Excision 12/2017 - 01/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2017 - 07/2004
3	Pain (Aches) 01/2017 - 02/2009
3	Hyperuricemia 09/2013 - 11/2010
2	Atrophy 06/2022 - 01/2019
2	Diabetes Mellitus 06/2022 - 09/2017
2	Seasonal Allergic Rhinitis (Hay Fever) 01/2022 - 01/2017
2	Ulcer 03/2021 - 09/2013
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
2	False Aneurysm (Pseudoaneurysm) 10/2020 - 06/2018
2	Cysts 08/2020 - 07/2009

Drug/Important Bio-Agent (IBA)

10	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2022 - 04/2009
9	SmokeIBA 12/2012 - 09/2005
6	Gemcitabine FDA Link 01/2021 - 10/2009
5	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2012
5	CollagenIBA 12/2021 - 03/2012
5	Uric Acid (Urate)IBA 05/2014 - 10/2008
4	C-Reactive ProteinIBA 06/2022 - 09/2016
4	AlbuminsIBA 04/2019 - 10/2014
4	EnzymesIBA 01/2019 - 11/2009
4	Proteins (Proteins, Gene)FDA Link 12/2014 - 03/2005
4	salicylhydroxamic acid (SHAM)IBA 09/2012 - 02/2004
3	CarbohydratesIBA 01/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2012
3	PlasticsIBA 05/2020 - 01/2005
3	Biological ProductsIBA 04/2019 - 03/2018
3	Amylases FDA Link 01/2019 - 08/2010
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 03/2005
3	Pharmaceutical PreparationsIBA 09/2016 - 01/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2011 - 12/2004
3	SolutionsIBA 01/2010 - 08/2005
3	fibrin fragment D (D-dimer)IBA 11/2009 - 11/2005
2	Amino Acids FDA Link 01/2022 - 08/2012
2	NeuropeptidesIBA 01/2022 - 12/2011
2	AllergensIBA 01/2022 - 01/2022
2	Immunoglobulin E (IgE)IBA 01/2022 - 01/2017
2	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 01/2022 - 06/2016
2	AntigensIBA 01/2022 - 01/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2021 - 01/2015
2	Thrombin FDA Link 01/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 09/2016
2	Prostaglandins AIBA 08/2020 - 01/2019

Therapy/Procedure

26	Therapeutics 01/2022 - 02/2002
16	Liver Transplantation 01/2021 - 08/2005
14	Pancreaticoduodenectomy 06/2022 - 05/2010
11	Chemoradiotherapy 01/2022 - 07/2012
10	Splenectomy 03/2018 - 07/2008
8	Hepatectomy 10/2020 - 04/2008
7	Pancreatectomy 06/2022 - 05/2012
7	Lasers (Laser) 05/2014 - 08/2007
6	Neoadjuvant Therapy 01/2022 - 10/2009
6	Drug Therapy (Chemotherapy) 07/2021 - 07/2004
6	Dye Lasers 03/2009 - 02/2006
5	Myocutaneous Flap 12/2022 - 01/2014
5	Ligation 05/2022 - 11/2012
4	Adjuvant Chemotherapy 05/2022 - 02/2015
4	Transplantation 01/2022 - 08/2009
4	Skin Transplantation (Skin Grafting) 06/2017 - 01/2005
3	Operative Surgical Procedures 06/2021 - 01/2017
3	Aftercare (After-Treatment) 11/2018 - 12/2007
3	Mammaplasty (Breast Reconstruction) 07/2018 - 05/2015
3	Debridement 08/2017 - 01/2005
3	Free Tissue Flaps 05/2017 - 01/2005
2	Negative-Pressure Wound Therapy 12/2021 - 12/2018
2	Surgical Amputation (Amputations) 12/2021 - 12/2018
2	Conservative Treatment 03/2021 - 07/2008